Skip to content

← All news

Digital Therapeutics

2 May 2025

At the World Health Innovation Summit (WHIS), we envision a future where healthcare is accessible, personalized, and equitable—a future powered by innovation. One of the most promising frontiers in that vision is the rise of Digital Therapeutics (DTx)—evidence-based software solutions designed to prevent, manage, or treat medical conditions.

Unlike wellness apps or health trackers, DTx are clinically validated interventions, often prescribed alongside or in place of traditional pharmaceuticals. From helping people manage chronic diseases like diabetes, to treating mental health conditions such as depression, anxiety, or insomnia, these digital tools are transforming care delivery across the globe.

The appeal of digital therapeutics lies in their scalability, affordability, and accessibility. Delivered through smartphones, tablets, or other connected devices, DTx enable continuous, personalized care that reaches patients wherever they are—at home, at work, or on the move. This is especially important for underserved communities and health systems facing workforce shortages or geographical barriers.

At WHIS, we see DTx not only as a technological innovation, but as a social equalizer. Our work supports the adoption of DTx across our programs—from WHISKids to WHISSeniors—empowering individuals to take control of their health through digital engagement, education, and evidence-based tools.

We collaborate with startups, clinicians, researchers, and policymakers to accelerate safe, effective DTx integration into mainstream care. Through our events, city innovation hubs, and international partnerships, we help amplify proven solutions and support health systems in deploying them at scale.

Critically, DTx also align with our values of preventive and personalized care. They provide real-time feedback, adapt to users’ needs, and collect data that helps clinicians make informed decisions. In mental health, for example, digital CBT programs are already helping thousands manage symptoms without long wait times or stigma.

But adoption must be thoughtful. WHIS advocates for strong ethical frameworks, data privacy protections, and equitable access to ensure DTx fulfill their promise without deepening digital divides. We work to ensure these innovations are clinically validated, culturally appropriate, and widely accessible—especially in low-resource settings.

In a world increasingly shaped by digital interactions, WHIS believes DTx can be a cornerstone of modern, resilient, and patient-centered healthcare systems. As we continue to support the global health community, we remain committed to bringing forward the tools, partnerships, and policies that make these powerful innovations a reality for all.